Immunological and apoptotic disturbances in children with congenital heart defects: pathogenetic aspects and diagnostic significance

L.V.  Mammadova; N.H.  Sultanova; A.G.  Hasanov; A.A.  Suleymanli

doi:10.15574/SP.2025.3(147).4146

Authors

L.V. Mammadova Azerbaijan Medical University, Baku, Azerbaijan https://orcid.org/0009-0005-0379-0110
N.H. Sultanova Azerbaijan Medical University, Baku, Azerbaijan https://orcid.org/0000-0003-4788-466X
A.G. Hasanov Azerbaijan Medical University, Baku, Azerbaijan https://orcid.org/0000-0002-0149-1943
A.A. Suleymanli Azerbaijan Medical University, Baku, Azerbaijan https://orcid.org/0009-0000-0162-3056

DOI:

https://doi.org/10.15574/SP.2025.3(147).4146

Keywords:

congenital heart defects, immunity, apoptosis, CD95, TNF-α, IL-6, children, hypoxia

Abstract

The aim of this study was to investigate immunological and apoptotic markers in children with congenital heart defects (CHDs) in order to assess their pathogenetic role and diagnostic significance.

Material and methods. A total of 114 children were enrolled and divided into three groups: patients with acyanotic CHDs (n=63), patients with cyanotic CHDs (n=28), and a control group of healthy children (n=23). All participants were evaluated for levels of CD3+, CD4+, CD8+, CD19+, CD16/56+, HLA-DR+, and CD95+ lymphocytes, as well as serum concentrations of IL-6 and TNF-α.

The results revealed significant differences between the clinical groups. Children with cyanotic CHDs demonstrated a marked decrease in CD3, CD4, and CD8 levels, along with a substantial increase in CD95 expression and pro-inflammatory cytokines, particularly TNF-α and IL-6 (p<0.01). These changes indicate immune system activation and enhanced apoptosis in the setting of chronic hypoxia.

Conclusion. Our findings confirm the pathogenetic relevance of immune and apoptotic disturbances in CHDs and highlight their potential diagnostic value.

The study was conducted in accordance with the principles of the Declaration of Helsinki. The study protocol was approved by the Local Ethics Committee for all participants. The informed consent was obtained from patients.

The authors declare no conflict of interest.

References

Alvi M, Mazhar M, Siddiqui A, Tariq S, Naqvi M, Rehman K et al. (2023). Clinical outcomes and TNF-α levels in cyanotic CHD. J Pediatr Surg. 58(2): 235-240.

Adams RH, Albrecht S, Schaefer C, Brunner H, Vogel T, Krüger R et al. (2023). Hypoxia-induced inflammation in congenital heart disease. Am J Physiol Heart Circ Physiol. 324(1): H123-H130.

Bae S, Lee J, Kim J, Park E, Yoon H, Lim M et al. (2023). IL-6 and TNF-α elevation in congenital heart disease. Pediatr Cardiol. 44(1): 59-67.

Chen Y, Xu Z, Wang J, Huang M, Lin C, Feng Y et al. (2021). Apoptotic pathways in pediatric heart failure: implications for therapy. Pediatr Cardiol. 42(5): 1125-1132.

Dutta P, Sadat M, Ahmad R, Malik A, Hussain M, Nasir A et al. (2022). Serum cytokine levels and hypoxia in children with CHD. Cytokine. 152: 155790.

Hoffman JIE, Kaplan S, Krabill KA, Moore L, Sinclair R, Jackson R et al. (2020). The incidence of congenital heart disease: a critical appraisal. J Am Coll Cardiol. 75(18): 2172-2179.

Jones R, Ahmed S, Patel N, Marquez F, Collins T, Rivas H et al. (2021). CD4+ T cell depletion and inflammation persistence in cyanotic CHD. J Pediatr Immunol. 19(3): 142-150.

Liu Y, Li L, Wang Y, Zhao X, Chen H, Zhang W et al. (2020). Expression of CD95 and myocardial remodeling in neonates with transposition of the great arteries. Cardiovasc Pathol. 47: 107221.

Lin Y, Xu D, Zhao Y, Liu Q, Wen J, Huang S et al. (2022). Apoptosis - inflammation interactions in pediatric cardiology. J Inflamm Res. 15: 567-576.

Menachem JN, Huddleston CB, Wheaton DK, Eldridge JM, Tran S, McAllister A et al. (2022). Immunologic profiling in children with congenital heart disease. Front Pediatr. 10: 821123.

Miller NR, Cooley SA, Downing JF, Singh P, Aref A, Johnson L et al. (2020). Postoperative immune response in pediatric cardiac surgery. Transl Pediatr. 9(5): 463-471.

Park C, Kim S, Han Y, Choi Y, Jung M, Song J et al. (2021). Role of immune markers in cardiac surgery outcomes. J Clin Med. 10(17): 3872.

Ranjan A, Verma SK, Sinha R, Agarwal R, Thakur R, Mishra D et al. (2021). Pediatric immune modulation in cyanotic heart defects. Indian J Pediatr. 88(11): 1021-1027.

Salinas P, de la Fuente J, Ortega F, Martinez A, Ruiz M, Sanchez M et al. (2024). Inflammatory and apoptotic biomarkers in cyanotic CHD. Cardiol Young. 34(1): 15-23.

Singh S, Kapoor PM, Juneja R, Das S, Mehta Y, Chowdhury U et al. (2020). Cytokine response and immune modulation in pediatric cardiac surgery. Ann Card Anaesth. 23(2): 158-164. https://doi.org/10.4103/aca.ACA_141_19; PMid:32687079 PMCid:PMC7559963

Van der Linde D, Konings EE, Slager MA, Witsenburg M, Helbing WA, Takkenberg JJ et al. (2021). Birth prevalence and mortality risk of congenital heart disease across the lifespan: a systematic review and meta-analysis. J Am Coll Cardiol. 79(10): 1033-1045.

Zhou W, Chen W, Zhang Y, Sun L, Tang Y, Liu F et al. (2022). Inflammatory cytokine expression in cyanotic congenital heart disease. Clin Exp Immunol. 207(1): 72-81.

Immunological and apoptotic disturbances in children with congenital heart defects: pathogenetic aspects and diagnostic significance

Authors

DOI:

Keywords:

Abstract

References

Downloads

Published

Issue

Section

License

Information

Developed By

Make a Submission